Resources
Lyophilized Peptide Specifications: Buyer Guide
How to read peptide identity, purity, content, moisture, analytical methods, packaging and release criteria without treating one headline number as the full specification.
How to read peptide identity, purity, content, moisture, analytical methods, packaging and release criteria without treating one headline number as the full specification.
Which parameters belong in a lyophilized peptide specification?
A useful specification identifies the material unambiguously and defines how an acceptable batch will be judged. Include the full peptide name, sequence, CAS number where applicable, salt or counter-ion form, molecular formula and molecular weight. Analytical requirements may cover identity by mass spectrometry, purity by a stated HPLC or UPLC method, peptide content or assay, appearance, water, residual solvents, counter-ion content and other product-specific tests. Not every test is appropriate for every peptide, so the specification should distinguish standard controls from project additions. Packaging, net quantity, storage condition, retest or expiry approach and document version also belong in the controlled record. Buyers should approve the specification before production or shipment and confirm that the COA reports against the same revision.
- Identity: sequence, mass and form
- Quality: method-linked acceptance criteria
- Composition: content, water and counter-ion
- Control: pack, storage and document revision
Is HPLC purity the same as peptide content?
No. HPLC purity usually expresses the relative chromatographic area assigned to the principal component under a defined method, while peptide content estimates how much peptide is present in the weighed material. The balance may include water, counter-ions, residual solvents, salts or other non-peptide components that are not represented by a single purity percentage. Method conditions, wavelength, integration rules and reference standards can also affect the reported value. For formulation or dosing calculations, buyers may need peptide content, net peptide, assay or another agreed quantitative basis in addition to chromatographic purity. Identity confirmation by mass spectrometry answers a different question again. A comparable quotation therefore states which value is being guaranteed, how it is measured and whether calculations use gross powder mass or confirmed peptide content.
- HPLC purity: relative chromatographic result
- Peptide content: quantitative composition estimate
- Identity: sequence-related mass confirmation
- Buyer action: define calculation basis
How should missing or variable specification data be handled?
Missing data should be marked for confirmation, not filled from a similar peptide, copied from a public database or inferred from a supplier image. Sequence, salt form and molecular weight must refer to the same chemical representation, and storage guidance should reflect actual stability knowledge for the specific form and package. During early sourcing, a catalog record can identify likely options, but the controlled specification becomes the purchasing reference. If a requested value is unavailable, decide whether to add testing, accept a justified alternative or remove that requirement based on intended use and risk. Record the decision in the quotation or quality agreement so that later batches are evaluated consistently. Any change to form, method, acceptance criterion, packaging or manufacturing route should trigger documented review.
- Unknown: label as pending confirmation
- Alternative: document technical justification
- Change: assess impact before approval
- Release: compare with agreed revision